One Stop Shop for All Your Market Research Reports

Global Bacteriophage Therapy Market Size, Status and Forecast 2021-2027

Phage therapy or viral phage therapy is the therapeutic use of bacteriophages to treat pathogenic bacterial infections. Bacteriophages, known as phages, are a form of viruses. Phages attach to bacterial cells, and inject a viral genome into the cell. Market Analysis and Insights: Global Bacteriophage Therapy Market The global Bacteriophage Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bacteriophage Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bacteriophage Therapy market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bacteriophage Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bacteriophage Therapy market. Global Bacteriophage Therapy Scope and Market Size Bacteriophage Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bacteriophage Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type Oral Topical Parenteral Segment by Application Organ Transplantation Bacterial Infections Alcoholic Hepatitis Other By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Nordic Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA By Company Armata Pharmaceuticals, Inc. Eliava Biopreparations Ltd. Pherecydes Pharma Intralytix, Inc. Phagelux Inc. Nextbiotics InnoPhage, Ltd Locus Biosciences, Inc. TechnoPhage Eligo Bioscience SA Phagomed Biopharma GmbH. PhagePro, Inc. Adaptive Phage Therapeutics, Inc. EnBiotix, Inc. Intodeworld, Inc. BiomX Ltd. Phi Therapeutics Fixed-phage Ltd. Micreos BV ContraFect Corporation
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Bacteriophage Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Oral 1.2.3 Topical 1.2.4 Parenteral 1.3 Market by Application 1.3.1 Global Bacteriophage Therapy Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Organ Transplantation
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3900
Multi User US $5850
Corporate User US $7800
About this Report
Report ID 786575
  • Healthcare
Published on 02-Dec
Number of Pages 126
Publisher Name QY Research
Editor Rating